- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06380569
A Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community Setting
July 22, 2024 updated by: Kessler Foundation
The investigators are looking to evaluate how effective a strength-based intervention may be in improving job interview skills in young adults.
The investigators are examining the effects of this intervention in young adults who may have difficulty with job interviews, and who may want to improve these skills.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The investigators have developed KF-STRIDE, a promising web-based intervention which focuses on helping autistic transition age youth improve interview skills by 1) learning to identify their unique employable strengths, and 2) practice speaking about those strengths to potential employers in socially appropriate ways.
The inability to express one's strengths to a potential employer can negatively affect interview performance and lead to difficulty with job obtainment.
Importantly, KF-STRIDE is web-based, so it is highly scalable, and uses well-established principles of positive psychology.
The investigators' pilot data evaluating KF-STRIDE in a lab-based setting indicates that after using KF-STRIDE, users experience increased knowledge of their personal strengths and improved job interview skills.
However, KF-STRIDE's effectiveness in a real-world setting has not been established.
Kessler Foundation (KF) Center for Autism Research will partner with Spectrum Works (or other community partner) (see letter of support) to implement and evaluate KF-STRIDE in a real-world setting.
Spectrum Works is a non-profit organization which provides job training and employment opportunities to autistic youth.
In the current study, KF-STRIDE will be implemented at Spectrum Works (or other community partner) by Spectrum Work staff members (trained by KF staff).
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Helen Genova, Ph. D.
- Phone Number: 973-324-8390
- Email: hgenova@kesslerfoundation.org
Study Contact Backup
- Name: Katarina Reduzzi, MA
- Email: kreduzzi@kesslerfoundation.org
Study Locations
-
-
New Jersey
-
East Hanover, New Jersey, United States, 07936
- Recruiting
- Kessler Foundation
-
Contact:
- Helen Genova, Ph. D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
Lives in the United States of America Between the ages of 14-26 Speaks English well and at a 4th grade reading level
Exclusion Criteria:
Had a stroke, Traumatic Brain Injury, or neurological injury or disease in the past(like brain tumor or epilepsy) Has a history of significant psychiatric illness(like schizophrenia or psychosis) Has uncontrolled seizures or other unstable medical complications
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment Group
In this arm, participants would participate in in an intervention program that uses character strengths to improve job maintenance skills in young adults.
|
Treatment group will receive 10 web based sessions of a strength-based training tool (once or twice a week).
Sessions are approximately 60 minutes long.
Other Names:
|
|
No Intervention: Control Group
In this arm, participants are services as usual and will participate in their regular activities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mock Job Interview
Time Frame: Baseline, Immediate Post-Test between weeks 7 and 8
|
Blinded reviewers using a standardized scoring measure will rate the video recorded mock job interviews
|
Baseline, Immediate Post-Test between weeks 7 and 8
|
|
Employment Status
Time Frame: Baseline, Immediate Post-Test, and 6 months Post-Test
|
We will examine whether the person became employed or other changes to their employment status.
Yes=1, No=0
|
Baseline, Immediate Post-Test, and 6 months Post-Test
|
|
Time-to-reach Employment
Time Frame: 6 months Post-Test
|
We will examine how long it took for the person to obtain employment.
Assessed as weeks since intervention completion.
|
6 months Post-Test
|
|
Strength Knowledge and Strengths Use Scale (SKUS)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Measure to assess knowledge and use of one's strengths and measure changes following strengths-based interventions.
Two scores: Strengths Use and Strengths Knowledge.
Strengths Use values range from 14-98, with higher score indicating a better outcome.
Strengths Knowledge values range from 8-56, with higher score indicating a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
|
Youth Interview- Self Efficacy and Anxiety
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
25 items combined, about confidence and interview comfort in adolescents, with values ranging from 0 to 5 for each item, and higher scores meaning a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
|
Job Search Behavior Scale
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
12 items measuring how often one engages in job search activities- language modified for use in youth, with values ranging from 1-5, with higher scores meaning a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
|
Work Readiness Scale
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
13 items about the perception of one's ability to work, with values ranging from 1 to 5, with higher scores meaning a better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
|
Global Assessment of Character Strengths (GACS)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
24 items measuring one's identification of personal character strengths, with values ranging from 1 to 5, with higher scores meaning a better outcome
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rosenberg Self-Esteem Scale (RSES)
Time Frame: Baseline, Immediate Post-test between weeks 7 and 8
|
Self-report self-esteem questionnaire.
Values range from 10-40, with higher score indicating better outcome.
|
Baseline, Immediate Post-test between weeks 7 and 8
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Helen Genova, Ph. D., Kessler Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2024
Primary Completion (Estimated)
June 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
April 18, 2024
First Submitted That Met QC Criteria
April 18, 2024
First Posted (Actual)
April 24, 2024
Study Record Updates
Last Update Posted (Actual)
July 24, 2024
Last Update Submitted That Met QC Criteria
July 22, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-1139-21 Community Setting
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
Clinical Trials on KF-STRIDE®
-
Kessler FoundationNot yet recruiting
-
Kessler FoundationCompleted
-
Kessler FoundationNot yet recruitingADHD | Dyslexia | Learning Disabilities
-
Kessler FoundationRecruiting
-
Kessler FoundationCompletedAutism Spectrum Disorder | Autism | ASDUnited States
-
Joslin Diabetes CenterBrown University; Theoria MedicalCompletedDiabetes | Dementia | Hypoglycemia; DrugUnited States
-
Keythera Pharmaceuticals (Australia) Pty LtdCompletedGastric Cancer | Colorectal Cancer | Lung Cancer | Bladder Cancer | Advanced Solid Tumor | Squamous Cell Carcinoma of the EsophagusAustralia
-
University of New MexicoNational Cancer Institute (NCI)CompletedValidate STRIDE Exercise Intervention in Sedentary Individuals | Increase Positive Attitudes, Perceived Normative Support, Self-efficacy, and Intentions | Increase Self-reported Physical ActivityUnited States
-
Kaiser PermanenteNot yet recruitingDiabetes Mellitus Type 2United States
-
Kessler FoundationRecruitingTraumatic Brain InjuryUnited States